Welcome to the new website of “Iztok-Zapad” – quality books, knowledge, and inspiration all in one place!
Anticancer: A New Way of Life

Anticancer: A New Way of Life

Sale -20%
  • 12.78€ / 25.00 лв.
  • 10.23€ / 20.00 лв.

Turn the Page. See the World: This month only, enjoy a 20% discount on all books.

Product Code:
471-01
ISBN
978-954-321-557-7
SKU
01.0147
Year
14-05-2009
Translation
From English: Ralitsa Derilova
Pages
392
Size
140/215 мм
Weight
0.5 kg
Cover Type
Paperback
Genre
Alternative Medicine, Conventional Medicine, Books About Cancer, Natural Medicine, Diets & Nutrition

David Servan-Schreiber

David Servan-Schreiber

David Servan-Schreiber (April 21, 1961 – July 24, 2011) was a French physician, neuroscientist and author. He was a clinical Professor of Psychiatry, University of Pittsburgh School of Medicine. He was also a lecturer in the Faculty of Medicine of Université Claude Bernard Lyon . Servan-Schreiber was born in Neuilly-sur-Seine, Hauts-de-Seine. He became co-founder and then director of the Centre fo…

Read more

Anticancer has been a bestselling phenomenon since Viking first published it in fall 2008. Now, a new edition addresses current developments in cancer research and offers more tips on how people living with cancer can fight it and how healthy people can prevent it.

The new edition of Anticancer includes:

• The latest research on anticancer foods, including new alternatives to sugar and cautions about some that are now on the market
• New information about how vitamin D strengthens the immune system
• Warnings about common food contaminants that have recently been proven to contribute to cancer progression
• A new chapter on mind-body approaches to stress reduction, with recent studies that show how our reactions to stress can interfere with natural defenses and how friendships can support healing in ways never before understood
• A groundbreaking study showing that lifestyle modification, as originally proposed in Anticancer, reduces mortality for breast cancer by an astounding 68 percent after completion of treatment
• New supporting evidence for the entire Anticancer program

There are no reviews for this product.